ERS Genomics and StemSight sign CRISPR/Cas9 license agreement
License agreement provides StemSight access to CRISPR/Cas9 technology to be applied in the development of cell therapies for corneal blindness
License agreement provides StemSight access to CRISPR/Cas9 technology to be applied in the development of cell therapies for corneal blindness
Automated parallel capillary electrophoresis system simplifies protein analysis
To be in with a chance to win a $500 Amazon.com Gift Card (or equivalent currency) cast your vote for the products which have had the biggest impact on laboratory sustainability
Discover the latest webinars, methods and products in gene editing technology
Dr. Julienne Carstens highlights the critical role of spatial biology in understanding the metastatic progression of PDAC and advancing personalized immunotherapy
In this guest editorial, discover how Capitainer® DBS cards with qDBS technology enable easy self-sampling with precision and accuracy
Scitara announces an agreement with Waters Corporation to bring greater lab connectivity
A recent study has revealed the effectiveness of COVID-19 vaccines in preventing long COVID
NeuMoDx CT/NG Assay, designed to improve accessibility, affordability and timeliness in sexually transmitted infection (STI) testing in the US
New research from Beckman Coulter Life Sciences highlights advancements in the identification of T-cell neoplasms
CELLBANKER® integrates into cell manufacturing processes with personalized formulations, volumes, and packaging
Shimadzu Scientific Instruments introduces its next-generation gas chromatograph mass spectrometer
Create rapid anaerobic, microaerobic and capnophilic conditions with the new system from Don Whitley Scientific
Researchers explore the challenges of scaling and combining quantum devices (qubits) for applications like climate modeling